Back
Phibro Animal Health Vs. Perspective Therapeutics Industry Stock Comparison
Buy
56
PAHC
Phibro Animal Health
Last Price:
18.00
Seasonality Move:
6.58%
Buy
61
CATX
Perspective Therapeutics
Last Price:
1.54
Seasonality Move:
2.36%
Buy
56
Phibro Animal Health (PAHC)
is a Buy
Is Phibro Animal Health a Buy, Sell or Hold?
- The current Phibro Animal Health [PAHC] share price is $17.98. The Score for PAHC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PAHC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.53. The Score for CATX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PAHC Stock Price Chart
What is Phibro Animal Health's stock price today?
-
The Phibro Animal Health share price today is $17.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PAHC is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.53
The current trend is moderately bearish and CATX is experiencing slight buying pressure.
PAHC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.3 | Buy |
| Relative Strength Index (14 RSI): | 71.16 | Buy |
| Chaikin Money Flow: | -65137 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.21 - 17.59) | Buy |
| Bollinger Bands (100): | (10.95 - 14.85) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 44.05 | Sell |
| Chaikin Money Flow: | 1336950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.51 - 1.77) | Sell |
| Bollinger Bands (100): | (0.65 - 1.51) | Buy |
PAHC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.72 | Buy |
| 20-day SMA: | 15.98 | Buy |
| 50-day SMA: | 14.05 | Buy |
| 200-day SMA: | 12.66 | Buy |
| 8-day EMA: | 17.65 | Buy |
| 20-day EMA: | 16.38 | Buy |
| 50-day EMA: | 14.68 | Buy |
| 200-day EMA: | 13.27 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.72 | Sell |
| 20-day SMA: | 1.69 | Sell |
| 50-day SMA: | 1.45 | Buy |
| 200-day SMA: | 0.7 | Buy |
| 8-day EMA: | 1.67 | Sell |
| 20-day EMA: | 1.65 | Sell |
| 50-day EMA: | 1.46 | Buy |
| 200-day EMA: | 0.9 | Buy |
Phibro Animal Health Earnings Growth & PAHC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.10 per share, and an increase next year of $0.26 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Phibro Animal Health Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||